Skip to main content

Advertisement

Table 3 Antibiotic Susceptibility pattern of isolated microorganisms in Dessie regional health research laboratory, May, 2012

From: Prevalence and antibiotic resistance pattern of urinary tract bacterial infections in Dessie area, North-East Ethiopia

Antibiotic E. coli Pseudomonas spps Proteus spps S. Aurous Klebsiela spps Entrobactor S. epidermidis N. gonorrhea Citrobactor
  Tt %S Tt %S Tt %S Tt %S Tt %S Tt %S Tt %S Tt %S Tt %S
Amoxicillin 182 28(15.4) 8 1/8 14 0/14 3 1/3 20 6(30.0) 5 0/5 5 1/5 1 1/1 1 0/1
Tetracycline 314 56(17.8) 16 6(37.5) 23 6(26.1) 10 3/10 26 9(34.6) 19 8(42.1) 4 0/4 2 1/2 7 0/7
TMP-SMX 231 56(24.2) 27 9(33.3) 17 6(35.3) 15 4/15 23 8(34.8) 15 12/15 8 2/8 1 0/1 4 ¾
Cephalothin 71 41(57.7) 8 0/8 10 3/10 2 1/3 5 5/5 7 2/7 5 2/5 1 0/1 2 ½
Ampicillin 45 9(20.0) 3 1/3 4 0/4 1 0/1 8 1/8 1 0/1 1 0/1 2 2/2 1 0/1
Chloramphenicol 201 104(51.0 15 12/15 16 5(31.3) 7 4/7 21 13(61.9 19 13(68.4) 4 2/4 2 2/2 5 3/5
Ceftriaxone 196 104(53.1 15 10/15 14 614 14 8/14 23 11(47.8 15 11/15 2 2/2 2 2/2 3 2/3
Ciprofloxacin 92 66(71.7) 43 41(95.3) 10 9/1 18 11(61.1) 10 6/4 17 15(88.2) 4 ¾ 3 1/3 5 4/5
Doxycyclin 62 22(35.5) 10 2/10 7 2/7 3 2/3 7 4/7 1 1/1 - - - - 1 0/1
Erythromycin 125 7(5.6) 39 7(17.9) 17 4(23.5) 27 10(37.0) 11 1/11 14 3/14 4 2/4 2 2/2 6 0/6
Gentamicin 362 239(66.0) 18 13(72.2) 25 16(64.0) 7 4/7 35 20(57.1) 19 16(84.2) 5 4/5 3 2/3 6 0/6
Kanamycin 145 116(80.0) - - 8 5/8 1 0/1 4 2/4 1 0/1 - - - - 2 0/2
Naldixic acid 105 91(86.7) - - 8 5/8 - - 9 9/9         
Nitrofurantoin 48 43(89.6) 4 4/4 4 4/4 3 3/3 6 4/6 6 5/6 - - 1 1/1 1 1/1
Penicillin G 2 ½ - - - - - - - - - - - - - - - -
Vancomycin 31 3(9.7) 9 1/9 3 0/3 3 0/3 1 0/1 - - - - - - 1 0/1
Furantoin 142 124(87.3) 1 0/1 13 5/13 1 1/1 24 16(66.7)    1 1/1    4 4/4
Carbencillin 127 42(33.1) 5 0/5 14 5/14 2 0/2 3 0/3 2 2/2 3 1/3    2 0/2
Clindamycin 26 16(61.5) 5 1/5 3 1/3 -- - 1 0/1 3 2/3 - - - - 2 ½
Bacitracin 45 13(28.9) - - 7 2/7 - - 4 ¼ - - 1 0/1   - - -
Streptomycin 10 1/10 - - - - - - 5 2/5 - - - - - - - -
Oxacyclin 12 12/12 3 2/3 1 0/1 1 0/1 - - 4 4/4 1 0/1 - - 1 0/1
  1. *Cut-off levels to establish sensitivity was done based on Oxoid the FDA susceptivity test interprative criteria available at: http://www.oxoid.com.
  2. **Abbreviations : T t Total tests, %S percent of sensitive results; for those samples ≤15 total sensitive/total tests (Ts/T t ) was used, TMP-SMX- trimetoprim-sulphamethoxazole, spps species.